315 related articles for article (PubMed ID: 14757977)
1. Iron status and oxidative stress in beta-thalassemia patients in Jakarta.
Laksmitawati DR; Handayani S; Udyaningsih-Freisleben SK; Kurniati V; Adhiyanto C; Hidayat J; Kusnandar S; Dillon HS; Munthe BG; Wirawan R; Soegianto RR; Ramelan W; Freisleben HJ
Biofactors; 2003; 19(1-2):53-62. PubMed ID: 14757977
[TBL] [Abstract][Full Text] [Related]
2. Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemia.
De Luca C; Filosa A; Grandinetti M; Maggio F; Lamba M; Passi S
Free Radic Res; 1999 Jun; 30(6):453-62. PubMed ID: 10400457
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major.
Mirlohi MS; Yaghooti H; Shirali S; Aminasnafi A; Olapour S
Ann Hematol; 2018 Apr; 97(4):679-684. PubMed ID: 29318368
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants.
Livrea MA; Tesoriere L; Pintaudi AM; Calabrese A; Maggio A; Freisleben HJ; D'Arpa D; D'Anna R; Bongiorno A
Blood; 1996 Nov; 88(9):3608-14. PubMed ID: 8896430
[TBL] [Abstract][Full Text] [Related]
5. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
6. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
Cazzola M; Borgna-Pignatti C; Locatelli F; Ponchio L; Beguin Y; De Stefano P
Transfusion; 1997 Feb; 37(2):135-40. PubMed ID: 9051086
[TBL] [Abstract][Full Text] [Related]
7. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
8. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.
Ozdemir ZC; Koc A; Aycicek A; Kocyigit A
Hemoglobin; 2014; 38(5):359-64. PubMed ID: 25222041
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of serum ferritin and iron burden by intake of antioxidants in beta thalassemia major.
Bhagat SS; Sarkar PD; Suryakar AN; Padalkar RK; Ghone RA; Patil SM; Hundekar PS
Indian J Physiol Pharmacol; 2013; 57(2):189-94. PubMed ID: 24617170
[TBL] [Abstract][Full Text] [Related]
10. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
11. Increased oxidative stress and iron overload in Jordanian β-thalassemic children.
Abdalla MY; Fawzi M; Al-Maloul SR; El-Banna N; Tayyem RF; Ahmad IM
Hemoglobin; 2011; 35(1):67-79. PubMed ID: 21250883
[TBL] [Abstract][Full Text] [Related]
12. Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions.
Kalleda N; Flace A; Altermatt P; Ingoglia G; Doucerain C; Nyffenegger N; Dürrenberger F; Manolova V
Haematologica; 2023 Oct; 108(10):2703-2714. PubMed ID: 37165842
[TBL] [Abstract][Full Text] [Related]
13. Oxidative status and malondialdehyde in beta-thalassaemia patients.
Cighetti G; Duca L; Bortone L; Sala S; Nava I; Fiorelli G; Cappellini MD
Eur J Clin Invest; 2002 Mar; 32 Suppl 1():55-60. PubMed ID: 11886433
[TBL] [Abstract][Full Text] [Related]
14. Association of iron overload and oxidative stress with insulin resistance in transfusion-dependent beta-thalassemia major and beta-thalassemia/HbE patients.
Tangvarasittichai S; Pimanprom A; Choowet A; Tangvarasittichai O
Clin Lab; 2013; 59(7-8):861-8. PubMed ID: 24133917
[TBL] [Abstract][Full Text] [Related]
15. Iron and oxidative stress in cardiomyopathy in thalassemia.
Berdoukas V; Coates TD; Cabantchik ZI
Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
[TBL] [Abstract][Full Text] [Related]
16. Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients.
Hatairaktham S; Masaratana P; Hantaweepant C; Srisawat C; Sirivatanauksorn V; Siritanaratkul N; Panichkul N; Kalpravidh RW
Ann Hematol; 2021 Apr; 100(4):891-901. PubMed ID: 33388858
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
Daar S; Pathare AV
Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
[TBL] [Abstract][Full Text] [Related]
18. Major Depression in Children with Transfusion-Dependent Thalassemia Is Strongly Associated with the Combined Effects of Blood Transfusion Rate, Iron Overload, and Increased Pro-inflammatory Cytokines.
Al-Hakeim HK; Najm AH; Al-Dujaili AH; Maes M
Neurotox Res; 2020 Jun; 38(1):228-241. PubMed ID: 32335809
[TBL] [Abstract][Full Text] [Related]
19. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
Said Othman KM; Elshazly SA; Heiba NM
Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
[TBL] [Abstract][Full Text] [Related]
20. Can N-acetylcysteine reduce red blood cell transfusion burden in patients with transfusion-dependent β-thalassemia?
Bahoush G; Rahab M; Ahmadvand P
Pediatr Hematol Oncol; 2024 May; 41(4):251-259. PubMed ID: 38088332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
